Dr. Ralph Moss has written the book, Questioning Chemotherapy, which documents the ineffectiveness of chemotherapy in treating most cancers. On November 19, 1977, he was fired for telling the public the truth. At a press conference on November 18th, he and the Second Opinion working group released a well-documented 48-page report that stated the top officials of the Memorial Sloan-Kettering Cancer Center had lied about the results of a study performed at the center regarding "Laetrile" -- (a natural, alternative cancer treatment).

Dr. Moss has gained credibility by writing eight books, including his most recent work, Cancer Therapy: The Independent Consumer's Guide to Non-Toxic Treatment. He also wrote The Cancer Industry, a documented research work telling of the enormous financial and political corruption in the "cancer establishment". He indicates that the motivating forces in cancer research and treatment are often power and money, and not the cure of cancer patients. He also writes, The Cancer Chronicles, a newsletter reporting on new cancer treatments and preventive measures.

Dr. Moss' work documents the ineffectiveness of chemotherapy on most forms of cancer. However, he is fair in pointing out that there are the following exceptions: Acute Lymphocytic leukemia, Hodgkin's disease, and nonseminomatous testicular cancer. Also, a few very rare forms of cancer, including choriocarcinoma, Wilm's tumor, and retinoblastoma. But all of these account for only 2% to 4% of all cancers occurring in the United States. This leaves some 96% to 98% of other cancers, in which chemotherapy doesn't eliminate the disease. The vast majority of cancers, such as breast, colon, and lung cancer are barely touched by chemotherapy. However, there is another category where chemotherapy has a relatively minor effect -- The most "successful" of these is in Stage 3 ovarian cancer, where chemotherapy appears to extend life by perhaps eighteen months, and small-cell lung cancer in which chemotherapy might offer six more months.

Read article at: http://www.mercola.com